• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声在分化型甲状腺癌患儿随访中的作用。

The role of ultrasound in the follow-up of children with differentiated thyroid cancer.

作者信息

Vali Reza, Rachmiel Marianna, Hamilton Jill, El Zein Mohamad, Wasserman Jonathan, Costantini Danny L, Charron Martin, Daneman Alan

机构信息

Department of Diagnostic Imaging, Division of Nuclear Medicine, The Hospital for Sick Children, University of Toronto, 555 University Ave., Toronto, ON, Canada, M5G 1X8,

出版信息

Pediatr Radiol. 2015 Jul;45(7):1039-45. doi: 10.1007/s00247-014-3261-0. Epub 2014 Dec 19.

DOI:10.1007/s00247-014-3261-0
PMID:25524437
Abstract

BACKGROUND

Thyroid cancer is the most common endocrine malignancy with relatively good prognosis in children. However, unlike adults, children usually present with more advanced disease and have a higher local recurrence and distant metastases. Thus surveillance for recurrence is a major goal of long-term follow-up.

OBJECTIVE

This retrospective study evaluates the diagnostic value of ultrasound (US) imaging in the post-therapy surveillance of children with differentiated thyroid cancer.

MATERIALS AND METHODS

We reviewed the charts of 54 children (40 girls; mean age 14.3 ± 3.6 years) with differentiated thyroid cancer treated with total or near-total thyroidectomy. Forty children (29 girls and 11 boys) who had routine follow-up US examinations (112 studies) were included for the evaluation of US accuracy in the follow-up of pediatric differentiated thyroid cancer. Histopathology, stimulated thyroglobulin determination, post-therapy whole-body iodine scan and clinical follow-up were used as the standards of reference.

RESULTS

Mean period of follow-up was 34 months. The frequency of recurrence was 42% (17/40). Seventeen percent of the children had lung metastases either at presentation or on follow-up. In all cases of lung metastases, stimulated thyroglobulin level was greater than 10 ng/ml. The sensitivity was 85.7%, specificity 89.4%, negative predictive value 94.4% and positive predictive value 75% for US in detecting loco-regional recurrence in follow-up studies of pediatric differentiated thyroid cancer. In 17.3% (18/104) of studies, the results of stimulated thyroglobulin and US were discordant.

CONCLUSION

US showed very good sensitivity and specificity and a high negative predictive value for evaluation of loco-regional involvement in follow-up of pediatric differentiated thyroid cancer. Diagnostic whole-body iodine scan is indicated when serum anti-thyroglobulin Ab is high, or in cases of discordant findings between US and stimulated thyroglobulin levels, or when stimulated thyroglobulin levels are >10 ng/ml (to evaluate for lung metastasis).

摘要

背景

甲状腺癌是儿童中最常见的内分泌恶性肿瘤,预后相对较好。然而,与成人不同的是,儿童通常表现为病情更晚期,局部复发和远处转移的发生率更高。因此,复发监测是长期随访的主要目标。

目的

本回顾性研究评估超声(US)成像在分化型甲状腺癌儿童治疗后监测中的诊断价值。

材料与方法

我们回顾了54例接受全甲状腺切除或近全甲状腺切除治疗的分化型甲状腺癌儿童(40名女孩;平均年龄14.3±3.6岁)的病历。纳入40例(29名女孩和11名男孩)进行常规随访超声检查(112项研究)的儿童,以评估超声在小儿分化型甲状腺癌随访中的准确性。组织病理学、刺激后甲状腺球蛋白测定、治疗后全身碘扫描和临床随访用作参考标准。

结果

平均随访时间为34个月。复发率为42%(17/40)。17%的儿童在初诊时或随访时有肺转移。在所有肺转移病例中,刺激后甲状腺球蛋白水平均大于10 ng/ml。在小儿分化型甲状腺癌随访研究中,超声检测局部区域复发的敏感性为85.7%,特异性为89.4%,阴性预测值为94.4%,阳性预测值为75%。在17.3%(18/104)的研究中,刺激后甲状腺球蛋白和超声的结果不一致。

结论

超声在评估小儿分化型甲状腺癌随访中的局部区域受累情况时显示出非常好的敏感性和特异性以及较高的阴性预测值。当血清抗甲状腺球蛋白抗体较高时,或超声与刺激后甲状腺球蛋白水平结果不一致时,或刺激后甲状腺球蛋白水平>10 ng/ml(用于评估肺转移)时,应进行诊断性全身碘扫描。

相似文献

1
The role of ultrasound in the follow-up of children with differentiated thyroid cancer.超声在分化型甲状腺癌患儿随访中的作用。
Pediatr Radiol. 2015 Jul;45(7):1039-45. doi: 10.1007/s00247-014-3261-0. Epub 2014 Dec 19.
2
Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence.初始治疗后对中高危复发风险分化型甲状腺癌患者行诊断性放射性碘全身扫描的价值。
Thyroid. 2012 Nov;22(11):1165-9. doi: 10.1089/thy.2012.0026. Epub 2012 Oct 10.
3
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.甲状腺球蛋白、放射性碘成像及正电子发射断层扫描在甲状腺癌评估中的各自作用。
Semin Nucl Med. 2006 Jul;36(3):194-205. doi: 10.1053/j.semnuclmed.2006.03.002.
4
Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?分化型甲状腺癌患者甲状腺球蛋白水平升高、I-131 全身扫描阴性时,可否普遍推荐使用 (18)F-FDG-PET/CT?
Ann Nucl Med. 2012 Jan;26(1):77-85. doi: 10.1007/s12149-011-0545-4. Epub 2011 Oct 19.
5
Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.(18)F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在甲状腺球蛋白升高且 (131)I 全身扫描阴性的分化型甲状腺癌患者中的诊断准确性:通过甲状腺球蛋白水平评估。
Ann Nucl Med. 2012 Jan;26(1):26-34. doi: 10.1007/s12149-011-0536-5. Epub 2011 Oct 5.
6
Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?使用重组人促甲状腺素进行诊断性碘-131扫描对甲状腺切除术后分化型甲状腺癌的随访是否有用?
J Clin Endocrinol Metab. 2002 Apr;87(4):1490-8. doi: 10.1210/jcem.87.4.8338.
7
Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.123I全身扫描及甲状腺球蛋白对分化型甲状腺癌转移灶或复发灶的检测敏感性
Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):768-74. doi: 10.1007/s00259-002-0781-x. Epub 2002 Mar 13.
8
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.在全甲状腺切除和放射性碘消融治疗后甲状腺癌分化型患者中,抗甲状腺球蛋白抗体阳性且甲状腺功能正常的患者随访期间血清促甲状腺激素升高时,诊断性全身扫描和血清甲状腺球蛋白的价值。
Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6.
9
Diagnostic value of recombinant human thyrotropin-stimulated ¹²³I whole-body scintigraphy in the follow-up of patients with differentiated thyroid cancer.重组人促甲状腺激素刺激¹²³I 全身显像在分化型甲状腺癌患者随访中的诊断价值。
Clin Nucl Med. 2012 Mar;37(3):229-34. doi: 10.1097/RLU.0b013e31823ea463.
10
Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.甲状腺切除术后行¹³¹I残留甲状腺组织消融时的血清甲状腺球蛋白水平,有助于早期预测低危分化型甲状腺癌患者的临床复发情况。
J Clin Endocrinol Metab. 2005 Mar;90(3):1440-5. doi: 10.1210/jc.2004-1771. Epub 2004 Dec 21.

引用本文的文献

1
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.2022年欧洲甲状腺协会儿童甲状腺结节和分化型甲状腺癌管理指南。
Eur Thyroid J. 2022 Nov 29;11(6). doi: 10.1530/ETJ-22-0146. Print 2022 Dec 1.
2
Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.儿科分化型甲状腺癌:英国国家临床实践共识指南。
Endocr Relat Cancer. 2022 Sep 7;29(11):G1-G33. doi: 10.1530/ERC-22-0035. Print 2022 Nov 1.
3
A systematic review of evidence for and against routine surveillance imaging after completing treatment for childhood extracranial solid tumors.

本文引用的文献

1
Recurrent differentiated thyroid cancer: to cut or burn.复发性分化型甲状腺癌:切除还是消融。
World J Surg Oncol. 2011 Aug 12;9:89. doi: 10.1186/1477-7819-9-89.
2
Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.甲状腺乳头癌和滤泡状癌患者的长期随访:对 715 例患者的前瞻性研究。
J Clin Endocrinol Metab. 2011 May;96(5):1352-9. doi: 10.1210/jc.2010-2708. Epub 2011 Mar 9.
3
Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.
儿童颅外实体瘤治疗后常规监测成像的证据进行系统评价:支持与反对。
Cancer Med. 2020 Jul;9(14):4949-4961. doi: 10.1002/cam4.3110. Epub 2020 May 19.
4
Update on thyroid ultrasound: a narrative review from diagnostic criteria to artificial intelligence techniques.甲状腺超声的最新进展:从诊断标准到人工智能技术的叙述性综述。
Chin Med J (Engl). 2019 Aug 20;132(16):1974-1982. doi: 10.1097/CM9.0000000000000346.
5
Utility of adult-based ultrasound malignancy risk stratifications in pediatric thyroid nodules.基于成人的超声恶性风险分层在儿童甲状腺结节中的应用价值。
Pediatr Radiol. 2018 Jan;48(1):74-84. doi: 10.1007/s00247-017-3974-y. Epub 2017 Oct 5.
目前的甲状腺球蛋白自身抗体(TgAb)检测方法常常无法检测到干扰性的 TgAb,这可能导致分化型甲状腺癌患者的血清 TgIMA 值被错误地报告为低值/检测不到。
J Clin Endocrinol Metab. 2011 May;96(5):1283-91. doi: 10.1210/jc.2010-2762. Epub 2011 Feb 16.
4
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.超声与 18-F-FDG PET 或 PET/CT 对疑似复发性甲状腺乳头状癌患者的诊断准确性。
Ultrasound Med Biol. 2010 Oct;36(10):1608-15. doi: 10.1016/j.ultrasmedbio.2010.07.013.
5
Normal and abnormal sonographic findings at the thyroidectomy sites in postoperative patients with thyroid malignancy.甲状腺恶性肿瘤术后患者甲状腺切除部位的正常和异常超声表现。
AJR Am J Roentgenol. 2010 Jun;194(6):1596-609. doi: 10.2214/AJR.09.2513.
6
Thyroid cancer in childhood: a retrospective review of childhood course.儿童甲状腺癌:对儿童期病程的回顾性研究
Thyroid. 2010 Apr;20(4):375-80. doi: 10.1089/thy.2009.0386.
7
Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008.215 例儿童和青少年甲状腺乳头癌患者的长期预后:1940 年至 2008 年的治疗结果。
World J Surg. 2010 Jun;34(6):1192-202. doi: 10.1007/s00268-009-0364-0.
8
Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy.使用超声和细针穿刺活检评估甲状腺癌淋巴结转移的诊断方法。
AJR Am J Roentgenol. 2010 Jan;194(1):38-43. doi: 10.2214/AJR.09.3128.
9
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.美国甲状腺协会修订的甲状腺结节和分化型甲状腺癌患者管理指南。
Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110.
10
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.小儿甲状腺癌:1753例患者的发病率及预后
J Surg Res. 2009 Sep;156(1):167-72. doi: 10.1016/j.jss.2009.03.098. Epub 2009 May 8.